Publications

Investing in life saving vaccines to guarantee life of future generations in Africa. 
Vaccine, 2016, 34, 5827–5832
Mihigo R.M., Okeibunor J.C., O’Malley H., Masresha B. , Mkanda P. , Zawaira F.  
http://www.sciencedirect.com/science/journal/0264410X

Secondhand smoke exposure and susceptibility to initiating cigarette smoking among never-smoking students in selected African countries:Findings from the Global Youth Tobacco Survey. 
Preventive Medicine, 2016, 91, S2–S8
Kyung A. Lee, Krishna M. Palipudi, Lorna M. English, Nivo Ramanandraibe , Samira Asma , on behalf of GYTS collaborative group.
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

Cigarette smoking and cigarette marketing exposure among students in selected African countries: Findings from the Global Youth Tobacco Survey.
Preventive Medicine, 2016, 91, S35–S39
Luhua Zhao, Krishna M. Palipudi , Nivo Ramanandraibe , Samira Asma. 
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

Youth access to cigarettes in six sub-Saharan African countries. 
Preventive Medicine, 2016, 91, S23–S27
Rachna Chandora, Yang Song , Martine Chaussard , Krishna Mohan Palipudi , Kyung Ah Lee , Nivo Ramanandraibe, Samira Asma , On behalf of GYTS collaborative group. 
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

An overview of tobacco control and prevention policy status in Africa. 
Preventive Medicine, 2016, 91, S16–S22
Muhammad Jami Husain, Lorna McLeod English, Nivo Ramanandraibe. 
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

Preventing tobacco epidemic in LMICs with low tobacco use — Using Nigeria GATS to reviewWHO MPOWER tobacco indicators and prevention strategies. 
Preventive Medicine, 2016 (91): S9–S15
Lazarous Mbulo, Nwokocha Ogbonna, Isiaka Olarewaju , Emmanuel Musa , Simone Salandy, Nivo Ramanandraibe, Krishna Palipudi , on behalf of GATS collaborative group.
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

Tobacco control in Africa. 
Preventive Medicine, 2016, 91: S1
Ahmed E. Ogwell O. 
http://www.sciencedirect.com/science/journal/00917435/91/supp/S

Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization. 
Journal of Tropical Pediatrics, 2016, 0, 1–8
Evans M. Mpabalwani et al. 
https://academic.oup.com/tropej/article/2525508/Review-of-Naturally-Occurring-Intussusception-in

Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.
International Journal of Mycobacteriology, 2016, 5(Supp1): S99–S100.
Tientcheu LD, Bell A, Secka O, Ayorinde A, Otu J, Garton NJ, Sutherland JS, Ota MO, Antonio M, Dockrell HM, Kampmann B, Barer MR. 
http://www.sciencedirect.com/science/article/pii/S2212553116301704

Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine. 
Vaccine,  2016, 34(41):5034-9. 
Idoko OT, Hampton LM, Mboizi RB, Agbla SC, Wallace AS, Harris JB, Sowe D, Ehlman DC, Kampmann B, Ota MO, Hyde TB. 
https://www.ncbi.nlm.nih.gov/pubmed/27570237

Developing the African national health research systems barometer. 
Health Research Policy and Systems, 2016, 14(1):53.
Kirigia JM, Ota MO, Senkubuge F, Wiysonge CS, Mayosi BM. 
https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-016-0121-4

The contribution of the polio eradication initiative to narrowing the gaps in the health workforce in the African Region.
Vaccine, 2016, 34(43):5150-5154
Kamso J, Mvika ES, Ota MO, Okeibunor J, Mkanda P, Mihigo R. 
https://www.ncbi.nlm.nih.gov/pubmed/27395564

Associations between nasopharyngeal carriage of Group B Streptococcus and other respiratory pathogens during early infancy.
BMC Microbiology, 2016, 16:97
Foster-Nyarko E, Kwambana B, Aderonke O, Ceesay F, Jarju S, Bojang A, McLellan J, Jafali J, Kampmann B, Ota MO, Adetifa I, Antonio M. 
http://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-016-0714-7

Host Immune Responses Differ between M.  africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.
PLoS neglected tropical diseases, 2016, 10(5)
Tientcheu LD, Haks MC, Agbla SC, Sutherland JS, Adetifa IM, Donkor S, Quinten E, Daramy M, Antonio M, Kampmann B, Ottenhoff TH, Dockrell HM, Ota MO. 
http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004701

Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults. 
Tuberculosis, 2016, 98: 86–91 
Owolabi O, Agbla S, Owiafe P, Donkor S, Togun T, Sillah AK, Ota MO, Sutherland JS. 
http://www.sciencedirect.com/science/article/pii/S1472979215302018

C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia. 
BMC infectious diseases, 2016, 16: 115.
Mendy J, Togun T, Owolabi O, Donkor S, Ota MO, Sutherland JS.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782376/

Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis. 
Tuberculosis (Edinb), 2016,96:31-6.
Sutherland JS, Mendy J, Gindeh A, Walzl G, Togun T, Owolabi O, Donkor S, Ota MO, Kon Fat ET, Ottenhoff TH, Geluk A, Corstjens PL. 
http://www.sciencedirect.com/science/article/pii/S1472979215301852

Productivity losses associated with tuberculosis deaths in the World Health Organization African region. 
Infectious Diseases of Poverty, 2016, 5: 43.
Joses Muthuri Kirigia and Rosenabi Deborah Karimi Muthuri. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888542/

Polio Eradication Initiative Best Practices in the WHOAfricanRegion.
Vaccine, 2016, 34(43):5141–5208.
Okeibunor J, Akanmori B, Mkanda P, Mihigo R. 
http://www.sciencedirect.com/science/article/pii/S0264410X1630384X

Polio Eradication Initiative: Contribution to improved communicable diseases surveillance in WHO African Region. 
Vaccine, 2016, 34(43): 5170–5174 
Alain Poy, Etienne Minkoulou, Keith Shaba, Ali Yahaya, Peter Gaturuku, Landoh Dadja, Joseph Okeibunor, Richard Mihigo, Pascal Mkanda.  
http://www.sciencedirect.com/science/article/pii/S0264410X16303863

Coordination as a Best Practice from the Polio Eradication Initiative: Experiences from Five Member States in the African Region of the World Health Organization.
Vaccine, 2016,34(43): 5203–5207
Joseph Okeibunor, Peter Nsubuga, Mbaye Salla, Richard Mihigo, Pascal Mkanda. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303929

Polio eradication initiative contribution in strengthening immunization and integrated disease surveillance data management in WHO African Region, 2014. 
Vaccine, 2016, Vaccine, 34, (43): 5181–5186
Alain Poy, Etienne Minkoulou, Keith Shaba, Ali Yahaya, Peter Gaturuku, Landoh Dadja, Joseph Okeibunor, Richard Mihigo, Pascal Mkanda. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303838

The Contribution of the Polio Eradication Initiative to Narrowing the Gaps in the Health Workforce in the African Region. 
Vaccine, 2016, 34, (43): 5150–5154
Jean Kamso, Eddy S. Mvika, Martin Ota, Joseph Okeibunor, Pascal Mkanda, Richard Mihigo. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303875

Experience of Integrating Vitamin A Supplementation into Polio Campaigns in the African Region. 
Vaccine, 2016, 34(43) : 5199–5202
Elizabeth Tangel Chehab, Blanche-Philomene Melanga Anya, Onyango Adelheid Werimo, Mable Carole Tevi-Benissan, Joseph Okeibunor, Pascal Mkanda, Richard Mihigo. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303826

Documentation of polio eradication initiative best practices: Experience from WHO African Region. 
Vaccine, 2016, 34(43): 5144–5149
Joseph Okeibunor, Deo Nshimirimana, Peter Nsubuga, Evariste Mutabaruka, Leonard Tapsoba, Emmanuel Ghali, Shaikh Humayun Kabir, Alex Gassasira, Richard Mihigo, Pascal Mkanda. 
http://www.sciencedirect.com/science/article/pii/S0264410X1630384X

Contribution of Polio Eradication Initiative to Effective New Vaccine Introduction in Africa, 2010 — 2015. 
Vaccine, 2016,34(43): 5193–5198
Mable Carole Tevi-Benissan, Edna Moturi, Blanche-Philomene Melanga Anya,  Teka Aschalew, Barthlomew Dicky Akanmori, Alain Nyembo Poy, Leon Kinuam Mbulu, Joseph Okeibunor, Richard Mihigo, Felicitas Zawaira. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303899

Polio infrastructure strengthened disease outbreak preparedness and response in the WHO African Region. 
Vaccine, 2016, 34(43) : 5175–5180
Koffi Kouadio, Joseph Okeibunor, Peter Nsubuga, Richard Mihigo, Pascal Mkanda. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303966

Reaching the unreached with polio vaccine and other child survival interventions through partnership with military in Angola. 
Vaccine, 2016, 34(43): 5155–5158
Lemma Fekadu, Joseph Okeibunor, Peter Nsubuga, Jean Marie Kipela, Pascal Mkanda, Richard Mihigo.
http://www.sciencedirect.com/science/article/pii/S0264410X16303954

Contribution of Polio Eradication Initiative to Strengthening Routine Immunization: Lessons Learnt in the WHO African Region. 
Vaccine, 2016. 34(43): 5187-5192
Blanche-Philomene Melanga Anya, Edna Moturi, Teka Aschalew, Mable Carole, Tevi-Benissan, Bartholomew Dicky Akanmori, Alain Nyembo Poy, Kinuam Leon Mbulu, Joseph Okeibunor, Richard Mihigo, Felicitas Zawaira. 
http://www.sciencedirect.com/science/article/pii/S0264410X16303887

Investing in Life Saving Vaccines to Guarantee Life of Future Generations in Africa. 
Vaccine, 2016, 34(48): 5827-5832 
Mihigo RM, Okeibunor JC, O'Malley H, Masresha B, Mkanda P, Zawaira F. 
http://www.sciencedirect.com/science/article/pii/S0264410X16304601

Community referral for presumptive TB in Nigeria: a comparison of four models of active case finding. 
BMC Public Health, 2016, 16:177.
Adejumo AO, Azuogu B, Okorie O, Lawal OM, Onazi OJ, Gidado M, Daniel OJ, Okeibunor JC, Klinkenberg E and Mitchell EMH. 
http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2769-7

Strategies for Communicable Diseases Response After Disasters in Developing Countries.
Kouadio KI, Kamigaki T, Oshitani H. 
Journal of Disaster Research, 2009, 4(5)
https://www.fujipress.jp/preview/

Outbreak of measles and rubella in refugee transit camps. 
Kouadio IK.  
Epidemiol. Infect, 2009, 137(11)
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=6191112&fileId=S0950268809002520

Measles outbreaks in displaced populations:a review of transmission, morbidity and mortality associated factors.
Kouadio IK, Kamigaki T, Oshitani H. 
BMC International Health and Human Rights, 2010, 10(5)
http://bmcinthealthhumrights.biomedcentral.com/articles/10.1186/1472-698X-10-5

Infectious diseases following natural disasters: prevention and control measures. 
Kouadio K I. et al. 
Expert Review of Anti-infective Therapy, 2012, 10(1):95-104 
http://www.tandfonline.com/doi/pdf/10.1586/eri.11.155

Enhancing the response outcome of infectious disease treatment following natural disasters. 
Kouadio IK, Aljunid SM, Oshitani H. 
Expert Review of Anti-infective Therapy, 2012, 10(5) 
http://www.tandfonline.com/doi/pdf/10.1586/eri.12.40

Incidence of bacterial meningitis in South East Asia region. 
Maimaiti et al. 
BMC Public Health, 2012, 12(Suppl 2)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507982/pdf/1471-2458-12-S2-A30.pdf

Beyond Knowledge and Awareness: Addressing Misconceptions in Ghana’s Preparation towards an Outbreak of Ebola Virus Disease. 
Adongo PB, Tabong PT-N, Asampong E, Ansong J, Robalo M, Adanu RM
PLoS ONE 11(2):e0149627. doi:10.1371/journal.pone.0149627

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Dièye S, Dieye TN, Esmail H, Goliath R, Huygen K, January V, Ndiaye I, Oni T, Raine M, Romano M, Satti I, Sutton S, Thiam A, Wilkinson KA, Mboup S, Wilkinson RJ, McShane H; MVA85A 030 trial investigators. 
Lancet Respir Med. 2015 Mar;3(3):190-200. doi: 10.1016/S2213-2600(15)00037-5. Epub 2015 Feb 26. PubMed PMID: 25726088.

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: a phase II randomized study.
Odutola A, Ota MO, Ogundare EO, Antonio M, Owiafe P, Worwui A, Greenwood B, Alderson M, Traskine M, Verlant V, Dobbelaere K, Borys D. Hum Vaccin Immunother.
2015 Nov 30:0. [Epub ahead of print] PubMed PMID: 26618243

Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa.
Nyaga MM, Jere KC, Esona MD, Seheri ML, Stucker KM, Halpin RA, Akopov A, Stockwell TB, Peenze I, Diop A, Ndiaye K, Boula A, Maphalala G, Berejena C, Mwenda JM, Steele AD, Wentworth DE, Mphahlele MJ.
Infect Genet Evol. 2015 Apr;31:321-34. doi: 10.1016/j.meegid.2015.02.011. Epub 2015 Feb 17.

Whole-genome analyses of DS-1-like human G2P[4] and G8P[4] rotavirus strains from Eastern, Western and Southern Africa.
Nyaga MM, Stucker KM, Esona MD, Jere KC, Mwinyi B, Shonhai A, Tsolenyanu E, Mulindwa A, Chibumbya JN, Adolfine H, Halpin RA, Roy S, Stockwell TB, Berejena C, Seheri ML, Mwenda JM, Steele AD, Wentworth DE, Mphahlele MJ.
Virus Genes. 2014 Oct;49(2):196-207. doi: 10.1007/s11262-014-1091-7. Epub 2014 Jun 22.

Cost of malaria morbidity in Uganda.
Orem JN, Kirigia JM, Azairwe R, Zikusooka CM, Bataringaya J, Ogwang PO.
Journal of Economics and Sustainable Development. 2012; 3(2): 58-80.

Impact of malaria morbidity on gross domestic product in Uganda.
Orem JN, Kirigia JM, Azairwe R, Kasirye I, Walker O.
International Archives of Medicine 2012, 5:12.
http://www.intarchmed.com/content/5/1/12

Estimation of the cost of large-scale school deworming programmes with benzimidazoles
A.Montresora,∗, A.F. Gabrielli a, A. Diarrab, D. Engelsa
Trans R Soc Trop Med Hyg (2009), doi:10.1016/j.trstmh.2009.10.007

Incidence of bacterial meningitis in South East Asia region. 
Maimaiti N, Isa ZM, Rahimi A, Kouadio KI, Ghazi HF, Aljunid SM. 
BMC Public Health 2012, 12(Suppl 2):A30. 
http://www.biomedcentral.com/1471-2458/12/S2/A30

Improving Malaria Diagnosis through Microscopy Competency Assessment Programs in Resource Limited Settings.
Bosco B Agaba, John Nyamuni, Elizabeth Streat, Moses Kamya, Charles Katureebe, Anthony Nuwa, Susann Nasir, Belay Kassahum, Bryan Kapella, Umaru Sekabira, Hope Ninsiima.
The American Journal of Tropical Medicine and Hygiene (AJTMH) 11/2014;Volume 91, No. 5 Supplement(November 2014):Page: 200

Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum. 
Ota MO, Mendy JF, Donkor S, Togun T, Daramy M, Gomez MP, Chegou NN, Sillah AK, Owolabi O, Kampmann B, Walzl G, Sutherland JS. 
Eur Respir J. 2014; 44:254-7. 

Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. 
Tientcheu LD, Sutherland JS, de Jong BC, Kampmann B, Jafali J, Adetifa IM, Antonio M, Dockrell HM, Ota MO. 
Eur J Immunol. 2014; 44:1387-98.  
http://www.ncbi.nlm.nih.gov/pubmed/24481948

Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African Trypanosomiasis.
Simarro et al.
International Journal of Health Geographics. 2014, 13:4

Epidemiology of human African trypanosomiasis.
Jose R Franco, Pere P Simarro, Abdoulaye Diarra, Jean G Jannin
Clinical Epidemiology. 2014:6

High Plasma Levels of Soluble Intercellular Adhesion Molecule (ICAM)-1 Are Associated with Cerebral 
Selorme Adukpo, Kwadwo A. Kusi, Michael F. Ofori, John K. A. Tetteh, Daniel Amoako-Sakyi, Bamenla Q. Goka, George O. Adjei, Dominic A. Edoh, Bartholomew D. Akanmori, Ben A. Gyan, Daniel Dodoo. 
Malaria. PLoS One 2013: 8 (12) 1-6 

Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis. 
Adewole OO, Ota MO, Erhabor GE, Owiafe P, Oladimeji A, Obaseki D.
Niger Med J. 2013; 54:376-81. 
http://www.ncbi.nlm.nih.gov/pubmed/24665150

Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. 
Sutherland JS, Loxton AG, Haks MC, Kassa D, Ambrose L, Lee JS, Ran L, van Baarle D, Maertzdorf J, Howe R, Mayanja-Kizza H, Boom WH, Thiel BA, Crampin AC, Hanekom W, Ota MO, Dockrell H, Walzl G, Kaufmann SH, Ottenhoff TH; the GCGH Biomarkers for TB consortium. 
Clin Microbiol Infect 2013;20:230-8.
http://www.ncbi.nlm.nih.gov/pubmed/24205913

Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa.
Sutherland JS, Lalor MK, Black GF, Ambrose LR, Loxton AG, Chegou NN, Kassa D, Mihret A, Howe R,
Mayanja-Kizza H, Gomez MP, Donkor S, Franken K, Hanekom W, Klein MR, Parida SK, Boom WH, Thiel BA, Crampin AC, Ota MO, Walzl G, Ottenhoff TH, Dockrell HM, Kaufmann SH; GCGH Biomarkers for TB consortium. 
PLoS One. 2013 Sep 10;8:e74080.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0074080

Diagnostic Utility of QuantiFERON-TB Gold In-Tube in active pulmonary tuberculosis in Nigeria. 
Adewole OO, Erhabor GE, Sogaolu MO, Onipede AO, Owiafe PK, Awopeju FO, Ota MO.
West Afr J Med. 2013;32:180-5.
http://www.ncbi.nlm.nih.gov/pubmed/24122682

Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination.
PP Simarro, JR Franco, A Diarra, JA Ruiz Postigo, J Jannin1
Research and Reports in Tropical Medicine. 2013:4 1–6

Household possession and use of insecticide-treated mosquito nets in Sierra Leone 6 months after a national mass-distribution campaign. 
Bennett A1, Smith SJ, Yambasu S, Jambai A, Alemu W, Kabano A, Eisele TP.
PLoS One. 2012;7(5)

Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010-January 2011.  
Wamala JF1, Malimbo M, Okot CL, Atai-Omoruto AD, Tenywa E, Miller JR, Balinandi S, Shoemaker T, Oyoo C, Omony EO, Kagirita A, Musenero MM, Makumbi I, Nanyunja M, Lutwama JJ, Downing R, Mbonye AK.
International Journal of Infectious Diseases. 2012 Jul; 16 (7) 

Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia.
Boeuf PS, Loizon S, Awandare GA, Tetteh JK, Addae MM, Adjei GO, Goka B, Kurtzhals JA, Puijalon O, Hviid L, Akanmori BD, Behr C.  
Malaria Journal 2012 ;11:253. 

Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. 
Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K. 
Malaria Journal 2012: 11:168. 

Interferon Gamma ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis: A clinical Trial. 
Adetifa IM, Ota MO, Jeffries DJ, Lugos MD, Hammond AS, Battersby NJ, Owiafe PK, Donkor SA, Antonio M, Ibanga HB, Brookes RH, Aka P, Walton R, Adegbola RA, Hill PC.
Am J Respir Crit Care Med 2012 Dec 13 (Epub ahead of Print).
http://www.ncbi.nlm.nih.gov/pubmed/23220919

Highly accurate diagnosis of pleural tuberculosis by immunological analysis of the pleural effusion. 
Sutherland JS, Garba D, Fombah AE, Mendy-Gomez A, Mendy FS, Antonio M, Townend J, Ideh RC, Corrah T, Ota MO. 
PLoS One. 2012;7(1):e30324. Epub 2012 Jan 
http://www.ncbi.nlm.nih.gov/pubmed/22295081

Estimating and Mapping the Population at Risk of Sleeping Sickness
Pere P. Simarro, Giuliano Cecchi, Jose´ R. Franco1, Massimo Paone, Abdoulaye Diarra, Jose´Antonio Ruiz-Postigo, Eric M. Fe`vre, Raffaele C. Mattioli2, Jean G. Jannin1
PLOS Neglected Tropical Diseases | www.plosntds.org 1 October 2012 | Volume 6 | Issue 10 | e1859

Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis.
Jose R Franco, Pere P Simarro, Abdoulaye Diarra, Jose A Ruiz-Postigo, Mireille Samo, Jean G Jannin1
Research and Reports in Tropical Medicine. 2012:3 93–101

Use of an innovative, affordable, and open-source short message service-based tool to monitor malaria in remote areas of Uganda. 
Asiimwe C1, Gelvin D, Lee E, Ben Amor Y, Quinto E, Katureebe C, Sundaram L, Bell D, Berg M:
American Journal of Tropical Medicine and Hygiene. 2011 Jul;85(1):26-33

Malaria treatment policy change and implementation: the case of Uganda. 
Nanyunja M1, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J.
Malar Res Treat. 2011; 2011:683167. 

Malaria control in the African Region: perceptions and viewpoints on proceedings of the Africa Leaders Malaria Alliance (ALMA). 
Sambo LG, Ki-Zerbo G, Kirigia JM.
BMC Proceedings 2011, 5(suppl 5): S3. 
http://www.biomedcentral.com/1753-6561/5/S5/S3

Risk for Human African Trypanosomiasis, Central Africa, 2000–2009.
Pere P. Simarro,1 Giuliano Cecchi, José R. Franco, Massimo Paone, Eric M. Fèvre, Abdoulaye Diarra, José Antonio Ruiz Postigo, Raffaele C. Mattioli, and Jean G. Jannin
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 12, December 2011

Possible interruption of measles virus transmission, Uganda, 2006-2009. 
Baliraine FN, Bwogi J, Bukenya H, Seguya R, Kabaliisa T, Kisakye A, Mbabazi WB, Smit SB
Emerging Infect Dis. 2011 Jan; 17 (1):110-3.  

Eradicating measles outbreaks in refugee camps. 
Kouadio KI. 
United Nations University Media Centre. November 2011. 
http://unu.edu/articles/population-health/eradicating-measles-outbreaks-in-refugee-camps

The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000–2009: The Way Forward
Pere P. Simarro1*, Abdoulaye Diarra2, Jose A. Ruiz Postigo3, Jose´ R. Franco1, Jean G. Jannin1
PLOS Neglected Tropical Diseases | www.plosntds.org 1  February 2011 | Volume 5 | Issue 2 | e1007

Measles Outbreaks in Displaced Populations: A Review of Transmission, Morbidity and Mortality Associated Factors. 
Kouadio KI, Kamigaki T, Oshitani H. 
BMC Int Health Hum Rights. 2010 Mar 19. 10:5
http://www.biomedcentral.com/1472-698X/10/5

Towards the Atlas of human African trypanosomiasis
Giuliano Cecchi, Massimo Paone, José R Franco, Eric M Fèvre, Abdoulaye Diarra, José A Ruiz, Raffaele C Mattioli and Pere P Simarro
International Journal of Health Geographics 2009, 8:15 doi:10.1186/1476-072X-8-15

Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda. 
Mbabazi WB1, Nanyunja M, Makumbi I, Braka F, Baliraine FN, Kisakye A, Bwogi J, Mugyenyi P, Kabwongera E, Lewis RF
Health Policy Plan. 2009 Jul; 24 (4):261-9.

Phylogenetic analysis of rubella viruses found in Morocco, Uganda, Cote d'Ivoire and South Africa from 2001 to 2007. 
Caidi H1, Abernathy ES, Benjouad A, Smit S, Bwogi J, Nanyunja M, El Aouad R, Icenogle J.
Journal Clinical Virology. 2008 May;42(1):86-90. 

Delivering new malaria drugs through grassroots private sector.
Chiguzo AN, Mugo RW, Wacira DG, Mwenda JM, Njuguna EW.
East Afr Med J. 2008 Sep;85(9):425-31.

Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. 
Ajayi IO1, Browne EN, Bateganya F, Yar D, Happi C, Falade CO, Gbotosho GO, Yusuf B, Boateng S, Mugittu K, Cousens S, Nanyunja M, Pagnoni F.
Malaria Journal. 2008 Sep 27; 7:190. 

Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in north-eastern Tanzania.
Vestergaard LS, Lusingu JP, Nielsen MA, Mmbando BP, Dodoo D, Akanmori BD, Alifrangis M, Bygbjerg IC, Lemnge MM, Hviid L, Theander TG.
Infection and Immunity 2008, 76:2706-2714

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.
Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Thiesen M
Malaria Journal 2008, 29:142

Validity of the concept of minor depression in a developing country setting.
Fekadu A, O'Donovan MC, Alem A, Kebede D, Church S, Johns L, Medhin G, Prince M, Shibre T. 
J Nerv Ment Dis. 2008 Jan;196(1):22-8. doi: 10.1097/NMD.0b013e31815fa4d4.
http://www.ncbi.nlm.nih.gov/pubmed/18195638 

V beta profiles in African children with acute cerebral or uncomplicated malaria: very focused changes  among a remarkable global stability 
Loizon S, Bouef P, Tetteh JK, Goka B, Obeng-Adjei G, Kurtzhals JA, Rogier C, Akanmori BD, Mercereau-Puijalon O, Hviid L, Behr C.
Microbes Infection 2007, 9(11):1252-9.

Complement activation in Ghanaian children with severe Plasmodium falciparum malaria. 
Helegbe GK, Goka BQ, Kurtzhals JA, Addae MM, Ollaga E, Tetteh JK, Dodoo D, Ofori MF, Obeng-Adjei, Hirayama K, Awandare GA, Akanmori BD
Malaria Journal 2007, 17:165   

La diversité écoclimatique et l’épidémiologie des schistosomiases au mali : implications pour un programme de controle 
M. Traoré, A. Landouré, A. Diarra, B. Kanté, M. Sacko, G. Coulibaly, A. Sangho & S. Y. Simaga
Mali Médical 2007 Tome XXII N° 3

Molecular characterisation of the rotavirus strains prevalent in Maua, Meru North, Kenya.
Kiulia NM, Peenze I, Dewar J, Nyachieo A, Galo M, Omolo E, Steele AD, Mwenda JM.
East Afr Med J. 2006 Jul;83(7):360-5.

Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?
Quashie NB, Akanmori BD, Ofori-Adjei D, Goka BQ, Kurtzhals JA
Journal of Tropical Paediatrics 2006, 52:254-259

Exposure of Ugandan health personnel to measles and rubella: evidence of the need for health worker vaccination.
Lewis RF1, Braka F, Mbabazi W, Makumbi I, Kasasa S, Nanyunja M.
Vaccine. 2006 Nov 17;24 (47-48):6924-9.

Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress.
Awandare GA, Goka B, Bouef P, Tetteh JK, Kurtzhals JA, Behr C, Akanmori BD
Journal of infectious Diseases 2006, 194:1438

New measles genotype, Uganda. 
Muwonge A1, Nanyunja M, Rota PA, Bwogi J, Lowe L, Liffick SL, Bellini WJ, Sylvester S. 
Emerging Infectious Diseases. 2005 Oct;11 (10):1522-6.

Pre-treatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment. 
Quashie NB, Akanmori BD, Goka BQ, Ofori-Adjei D and Kurtzhals JAL. 
Journal of Tropical Paediatrics 2005, 51, 149-153

Bone marrow suppression and severe malaria associated with persistent Plasmodium falciparum infection in African children with microscopically undetected parasitaemia.
Helleberg M, Goka BQ, Akanmori BD, Obeng-Adjei G, Rodrigues O, Kurtzhals JA
Malaria Journal 2005, 4:56 

Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens. 
Nielsen MA, Vestergaard LS, Lusingu J, Kurtzhals JAL, Giha H, Grevstad B, Goka BQ, Lemnge M, Jensen JB, Akanmori BD, Staasoe T and Hviid L. 
Infection and immunity 2004 72(6):3531-5. 

Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria.
David R. Cavanagh, Daniel Dodoo, Lars Hviid, Jorgen A.L. Kurtzhals, Thor G. Theander, Bartholomew D. Akanmori, Spencer Polley, David J. Conway, Kojo Koram, Jana S. McBride
Infection and Immunity 2004 72(11):6492-502.

Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, Ethiopia.
Araya T, Reniers G, Schaap A, Kebede D, Kumie A, Nagelkerke N, Coutinho R, Sanders E. 
Trop Med Int Health. 2004 Jan;9(1):178-86.  
http://www.ncbi.nlm.nih.gov/pubmed/14728623

Behavioural survey for HIV/AIDS infection in Asosa, among the general population and commercial sex workers
Eshetu M, Kebede D, Ismail S, Sanders E, Wolday D, Messele T, Tegbaru B, Worku A.
Ethiop. J Health Dev. 2004; 18(2):75-81 
http://www.ajol.info/index.php/ejhd/article/view/9941

Experimental infection of the olive baboon (Paplio anubis) with Plasmodium knowlesi: severe disease accompanied by cerebral involvement.
Ozwara H, Langermans JA, Maamun J, Farah IO, Yole DS, Mwenda JM, Weiler H, Thomas AW.
Am J Trop Med Hyg. 2003 Aug;69(2):188-94

Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites.
Ozwara H, Langermans JA, Kocken CH, van der Wel A, van der Meide PH, Vervenne RA, Mwenda JM, Thomas AW.
Infect Immun. 2003 Aug;71(8):4375-81.

Transforming growth factor-β, interleukin (IL)-18, and IL-12:Effect on the clinical course and complications of Plasmodium falciparum malaria. (Correspondence)
Eleanor M. Riley, Omer F.M., Dodoo D. and B.D. Akanmori
Journal of Infectious Diseases 2003, 187:339

Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of  in clinically immune pregnant women indicates ongoing placental infection
Ofori MF, Staalsoe S, Bam V, Lundquist M, David KP, Browne ENL, Akanmori BD and Hviid L. 
Infection and Immunity 2003, 71(3):1584-1586

Severe malaria in West African children. (Correspondence). 
Kurtzhals JAL, Helleberg M, Goka BQ, Akanmori BD. 
Lancet 2003, 361(9366):1393 

Genetic diversity and antigenic polymorphism in Plasmodium falciparum malaria: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2.
Simon Franks, Luke Baton, Kevin Tetteh, Eric Tongren, David Dewin, Bartholomew D. Akanmori, Kojo A. Koram, Lisa Ranford-Cartwright and Eleanor M. Riley 
Infection and Immunity 2003, 71:3485-3494

Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum infected erythrocytes.
Peter Garred, Morten A. Nielsen, Jørgen A.L. Kurtzhals, Rajneesh Malhotra, Hans O. Madsen, Bamenla Q. Goka, Bartholomew D. Akanmori, Robert B. Sim and Lars Hviid
Journal of Infectious Diseases 2003, 71(9), 5245-5253

Cryptosporidium oocysts in Ghanaian AIDS patients with diarrhoea.
Adjei A, M Lartey, TK Adiku, O Rodrigues, L Renner, E Sifah, JD Mensah, B Akanmori, J Otchere, BK Bentum and KM Bosompem. 
East African Medical Journal 2003, 80 (7), 369-372

Comparison of chloroquine with quinimax in the treatment of cerebral malaria in Ghanaian children 
Bamenla Q Goka, Onike P Rodrigues, G Obeng Adjei, B Quarshie, BD  Akanmori,  JAL. Kutzhals Janet Neequaye..
Ghana Medical Journal, 2003, 37(3): 110-116

Mortality impact of AIDS in Addis Ababa, Ethiopia.
Sanders EJ, Araya T, Kebede D, Schaap AJ, Nagelkerke ND, Coutinho RA. 
Ethiop Med J. 2003 Jun;41 Suppl 1:35-42.
http://www.ncbi.nlm.nih.gov/pubmed/15227879

Human group C rotaviruses identified in Kenya.
Mwenda JM, Peenze I, Omollo E, Galo M, Steele AD.
East Afr Med J. 2003 Feb;80(2):73-6.

Plasmodium knowlesi provides a rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies.
Kocken CH, Ozwara H, van der Wel A, Beetsma AL, Mwenda JM, Thomas AW.
Infect Immun. 2002 Feb;70(2):655-60.

Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.
Kåre Kemp, Bartholomew D Akanmori, Victoria Adabayeri, Bamenla Q Goka, Jørgen AL Kurtzhals Charlotte Behr &Lars Hviid
Clinical and Experimental Immunology 2002:127:151-7.

Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and non-severe malaria and is modified by acquired immunity. 
Nielsen MA, Staalsoe T, Kurtzhals JAL, Goka BQ, Dodoo D, Alifrangis M,Theander TG, Akanmori BD and Hviid L. 
Journal of Immunology, 2002, 168:3444-3450

Absolute levels and ratios of pro-inflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to P. falciparum malaria. 
Dodoo D., F. M. Omer, J. Todd, B. D. Akanmori, K. Koram and E Riley
Journal of Infectious Diseases  2002, 185:971-9.

Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens.
Michael Ofori, Dodoo D., Staalsoe S., Kurtzhals J.A.L. Koram K, Theander T. Akanmori B. D. and L.Hviid
Infection and Immunity 2002, 70 (6): 2982-2988.

Increased Levels of Soluble CD30 in Plasma of Patients with Plasmodium falciparum Malaria 
Kemp K, Kurtzhals JAL, Akanmori BD, Adabayeri V, Goka BQ, Behr C and Hviid L.
Clinical Diagnosis and Laboratory Immunology 2002, 9:720-722. 

Elevated levels of nitric oxide and low levels of haptoglobin associated with severe malarial anaemia in African children.
Gyan B.A, Kurtzhals J.A.L., Akanmori B.D., Ofori M.F., Goka B.Q., Hviid L. and Behr. C. 
Acta Tropica 83: 133-140, 2002

Acute Plasmodium falciparum malaria induces a loss of CD28- T IFN- producing cells.
Kemp, K., Akanmori B.D., Kurtzhals J.A.L., Adabayeri V., Goka B.Q. and L. Hviid 
Parasite Immunology 2002, 24(11-12):545-548 

Polymorphisms in Interleukin-1beta and Interleukin-1 Receptor Antagonist Genes and Malaria in Ghanaian Children.
Gyan B, Goka B, Cvetkovic JT, Perlmann H, Lefvert AK, Akanmori B, Troye-Blomberg M.
Scandinavian Journal of Immunology 2002, 56(6):619-622.

Impact of HIV/AIDS on gross domestic product (GDP) in the WHO African Region.
Kirigia JM, Sambo LG, Okorosobo T and Mwabu G. (2002).
African Journal of Health Sciences, 9(1-2): 27-39. 
http://www.ajol.info/index.php/ajhs/issue/view/4283

Comparison of chloroquine with artesunate in the treatment of cerebral  malaria in Ghanaian children.
Bamenla Q. Goka, Victoria Adabayeri, Eugenia Ofori-Adjei, Ben Quarshie, Gladys Asare-Odei, Bartholomew D. Akanmori, Jorgen Kurtzhals, David Ofori-Adjei, Janet Neequaye. 
Journal of Tropical Paediatrics 2001, 47, 34-38

Antibodies to variant antigens on the surface of infected erythrocytes are associated with protection from malaria in Ghanaian children. 
Daniel Dodoo, Trine Staalsoe, Haidaer Giha, Jorgen AL. Kurtzhals, Bartholomew D. Akanmori, Kojo Koram, Samuel Dunyo, Francis K. Nkrumah, Lars Hviid and ThorTheander. 
Infection and Immunity 2001, 69:3713-3718

The importance of strict patient definitions in studies of malaria pathogenesis.
Jorgen AL. Kurtzhals, Bamenla Q. Goka, Bartholomew D. Akanmori, Lars Hviid
Trends in Parasitology 2001, 17(5).

Perturbation and pro-inflammatory type activation of Vd1+ gd T cells in African children with Plasmodium falciparum malaria.    
Hviid L, Kurtzhals JAL, Adabayeri V, Loizon S, Kemp K, Goka BQ, Lim A, Mercereau-Puijalon O, Akanmori BD and Behr C. 
Infection and Immunity 2001, 69(5), 3190-3196

Malaria Immunology and Pathogenesis Consortium  (MIMPAC) formed
B. D. Akanmori 
Trends in Parasitology 2001, 17(5) 

Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria 
Michelle S.M. Rhee, Bartholomew D. Akanmori, Martin Waterfall & Eleanor M. Riley. 
Clinical and Experimental Immunology 2001, 126(3), 503-10.

Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria 
Goka BQ, Kwarko H, Kurtzhals JAL, Gyan B, Ofori-Adjei E, Ohene SA, Hviid L, Akanmori BD and Neequaye J. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2001:95,545-549

Evaluation of Non-radioactive ELISA assay Kits for Detection of Retroviral Reverse Transcriptase (RT) Activity Associated with Retroviral SIV and HIV.
Lang'at DK, Sichangi MW, Kiio M, Ochiel D, Kyama C, Otsyula M, Mwenda JM.
Afr J Health Sci. 2001 Jan-Jun;8(1-2):39-46.

Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175.
Ozwara H, Kocken CH, Conway DJ, Mwenda JM, Thomas AW.
Mol Biochem Parasitol. 2001 Aug;116(1):81-4. No abstract available. 

Differential regulation of TNF and its receptors in discrete clinical forms of P. falciparum malaria.
Bartholomew D. Akanmori, Jørgen A. L. Kurtzhals, Bamenla Goka, Victoria Adabayeri, Michael F. Ofori, Francis K. Nkrumah, Charlotte Behr, &Lars Hviid   
European Cytokine Network 2000, 11(1):113-118

Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria
Isaac K. E. Quaye, Fred A. Ekuban, Bamenla Q. Goka, Victoria Adabayeri, Jørgen A. L. Kurtzhals, Ben Gyan, Nii-Ayi Ankrah, Lars Hviid & Bartholomew D Akanmori 
Transactions of the Royal Society of Tropical Medicine and Hygiene 2000; 94:216-219

Naturally acquired antibodies to glutamate rich protein (GLURP) are associated with protection against Plasmodium falciparum malaria.
Daniel Dodoo, Michael Theisen, Jørgen AL Kurtzhals, Bartholomew D Akanmori, Kojo Koram, Søren Jepsen, Francis K Nkrumah, Thor G Theander & Lars Hviid
Journal of Infectious Diseases 2000;181:1202-1205 

Prevalence of tuberculosis in cattle in the Dangme-West district of Ghana, public health implications.
Bonsu, O.A, E. Laing, & B.D. Akanmori
Acta Tropica 2000, 76(1):9-14

Seroprevalence of brucellosis in cattle and humans in the Akwapim-South District of Ghana :public health implications
Kubuafor D.K, B. Awumbila & B.D. Akanmori 
Acta Tropica 2000, 76(1): 45-48

Human behavioural factors responsible for the outbreaks of human anthrax in  the Tamale municipality of northern Ghana
Opare C., A. Nsiire, B. Awumbilla & B. D. Akanmori
Acta Tropica 2000, 76(1):49-52

Detection and management of zoonotic diseases at the Kumasi slaughterhouse in `Ghana.
Otupiri, E. , Adam M., Laing, E. & B.D. Akanmori. 
Acta Tropica 2000, 76(1):15-19

Seroprevalence of toxoplasmosis in pigs in Ghana
Arko-Mensah J., K.M. Bosompem, E.A. Canacoo, JM. Wastling & B.D. Akanmori
Acta Tropica 2000, 76(1):27-31

The Prevalence of anti-Toxoplasma gondii antibodies in Ghanaian Sheep and Goats 
Van der Puije W.N., K.M. Bosompem, E.A. Canacoo, J.M. Wastling & B.D. Akanmori. 
Acta Tropica 2000, 76(1):21-26

Haptoglobin Phenotypes in HIV-1-Seropositive Patients in Ghana: Decreased Risk for Hp0 Individuals.
I.K.E.Quaye, F.A.Ekuban, J.A.M. Brandful, B.A. Gyan, B.D. Akanmori, N-A. Ankrah
Human Heredity 2000, 50(6):382-283

A cost-benefit analysis of preventive schistosomiasis interventions in Kenya. 
Kirigia J.M., Sambo, L.G. and Kainyu L.H. (2000). 
African Journal of Health Sciences, 7(3-4): 5-11. 
http://www.ncbi.nlm.nih.gov/pubmed/17650020

Expression of endogenous HIV-1 crossreactive antigens within normal human extravillous trophoblast cells.
Lyden TW, Johnson PM, Mwenda JM, Rote NS.
J Reprod Immunol. 1995 Mar;28(3):233-45